Gene · 2207
Papers2,891
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,891
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. | MAbs | 2023 | 37165468 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| T cell-derived exosomes in tumor immune modulation and immunotherapy. | Front Immunol | 2023 | 37153615 | PubTator, text mining | PubMed |
| New cell sources for CAR-based immunotherapy. | Biomark Res | 2023 | 37147740 | PubTator, text mining | PubMed |
| Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions. | Am J Clin Dermatol | 2023 | 37140884 | PubTator, text mining | PubMed |
| Aryl-functionalised α,α'-Trehalose 6,6'-Glycolipid Induces Mincle-independent Pyroptotic Cell Death. | Inflammation | 2023 | 37140682 | PubTator, text mining | PubMed |
| Applying causal discovery to single-cell analyses using CausalCell. | Elife | 2023 | 37129360 | PubTator, text mining | PubMed |
| Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8+ T cells. | Sci Immunol | 2023 | 37115913 | PubTator, text mining | PubMed |
| PGLYRP1-mIgG2a-Fc inhibits macrophage activation via AKT/NF-κB signaling and protects against fatal lung injury during bacterial infection. | iScience | 2023 | 37113764 | PubTator, text mining | PubMed |
| Targeting B7-H3-A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment. | Molecules | 2023 | 37110590 | PubTator, text mining | PubMed |
| Inhibition of BET Proteins Regulates Fcγ Receptor Function and Reduces Inflammation in Rheumatoid Arthritis. | Int J Mol Sci | 2023 | 37108786 | PubTator, text mining | PubMed |
| Facilitator competency rubric in nursing simulations: transcultural adaptation and validation of the German version. | BMC Nurs | 2023 | 37101256 | PubTator, text mining | PubMed |
| Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. | Blood Cancer J | 2023 | 37095094 | PubTator, text mining | PubMed |
| Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps. | Sci Rep | 2023 | 37085563 | PubTator, text mining | PubMed |
| CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. | Med Oncol | 2023 | 37083979 | PubTator, text mining | PubMed |
| The inhibitory effect of isoliquiritigenin on human platelets in vitro. | Ann Transl Med | 2023 | 37082661 | PubTator, text mining | PubMed |
| Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients. | Cancer Immunol Immunother | 2023 | 37081323 | PubTator, text mining | PubMed |
| Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37071001 | PubTator, text mining | PubMed |
| T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors. | Cancer Immunol Res | 2023 | 37070661 | PubTator, text mining | PubMed |
| Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis. | Genet Res (Camb) | 2023 | 37065178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2207/papers?page=18